Nexalis Therapeutics Limited (ASX:NX1)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
At close: Mar 9, 2026
Nexalis Therapeutics Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | - | - | 0.02 | 0.18 | Upgrade
|
| Other Revenue | 0.77 | 0.4 | 1.2 | - | - | Upgrade
|
| Revenue | 0.77 | 0.4 | 1.2 | 0.02 | 0.18 | Upgrade
|
| Revenue Growth (YoY) | 91.06% | -66.63% | 4755.02% | -86.35% | 721.35% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.12 | Upgrade
|
| Gross Profit | 0.77 | 0.4 | 1.2 | 0.02 | 0.07 | Upgrade
|
| Selling, General & Admin | 0.67 | 1.02 | 1.08 | 0.89 | 0.99 | Upgrade
|
| Research & Development | 1.76 | 0.62 | 1.45 | 0.98 | 0.12 | Upgrade
|
| Other Operating Expenses | 0.02 | 0.02 | 0.04 | 0.08 | 0.07 | Upgrade
|
| Operating Expenses | 2.46 | 1.68 | 2.63 | 1.98 | 1.18 | Upgrade
|
| Operating Income | -1.69 | -1.28 | -1.42 | -1.95 | -1.11 | Upgrade
|
| Interest Expense | -0.14 | -0.09 | -0.01 | - | - | Upgrade
|
| Interest & Investment Income | - | 0 | 0 | 0.02 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.15 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.83 | -1.21 | -1.43 | -1.94 | -1.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - | Upgrade
|
| Asset Writedown | - | - | -0.01 | - | - | Upgrade
|
| Pretax Income | -1.83 | -1.21 | -1.44 | -1.93 | -1.11 | Upgrade
|
| Earnings From Continuing Operations | -1.83 | -1.21 | -1.44 | -1.93 | -1.11 | Upgrade
|
| Net Income | -1.83 | -1.21 | -1.44 | -1.93 | -1.11 | Upgrade
|
| Net Income to Common | -1.83 | -1.21 | -1.44 | -1.93 | -1.11 | Upgrade
|
| Shares Outstanding (Basic) | 216 | 213 | 189 | 173 | 168 | Upgrade
|
| Shares Outstanding (Diluted) | 216 | 213 | 189 | 173 | 168 | Upgrade
|
| Shares Change (YoY) | 1.06% | 12.72% | 9.42% | 3.27% | 68.94% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | -0.89 | -0.37 | -1.96 | -1.85 | -1.16 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 36.59% | Upgrade
|
| Operating Margin | -220.50% | -318.39% | -118.22% | -7879.43% | -611.57% | Upgrade
|
| Profit Margin | -238.28% | -300.98% | -119.87% | -7770.36% | -611.38% | Upgrade
|
| Free Cash Flow Margin | -115.69% | -91.78% | -162.94% | -7444.75% | -638.32% | Upgrade
|
| EBITDA | - | - | -1.41 | -1.94 | -1.11 | Upgrade
|
| EBITDA Margin | - | - | -117.42% | - | - | Upgrade
|
| D&A For EBITDA | - | - | 0.01 | 0.01 | 0 | Upgrade
|
| EBIT | -1.69 | -1.28 | -1.42 | -1.95 | -1.11 | Upgrade
|
| EBIT Margin | -220.50% | - | -118.22% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.